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Abstract. 
 
Within the clathrin-coated vesicle (CCV) cy-
cle, coat assembly drives the internalization of recep-
tors from the cell surface and disassembly allows for the
processing of internalized ligands. The heat shock cog-
nate protein, hsc70, has been implicated in regulating
coat disassembly. We ﬁnd that in cells overexpressing
ATPase-deﬁcient hsc70 mutants, uncoating of CCVs is
inhibited in vivo, and the majority of unassembled cyto-
solic clathrin shifts to an assembled pool that cofrac-
tionates with AP1 and AP2. Surprisingly, this assembled
pool of coat proteins accumulates in the absence of
cargo receptors, suggesting that disruption of hsc70 ac-
tivity may cause misassembly of empty clathrin cages.
The strongest effect of overexpression of hsc70 mutants
is a block in transferrin receptor (TfnR) recycling,
which cannot be accounted for by the degree of inhibi-
tion of uncoating of endocytic CCVs. These results sug-
gest that hsc70 participates in multiple transport and/or
sorting events between endosomal compartments. Ad-
ditionally, the mutant-expressing cells are defective at
internalizing transferrin. In the most potent case, the
initial rate of uptake is inhibited 10-fold, and TfnR lev-
els double at the cell surface. Our ﬁndings demonstrate
that hsc70 indeed regulates coat disassembly and also
suggest that this chaperone broadly modulates clathrin
dynamics throughout the CCV cycle.
Key words: Hsc70 • endocytosis • clathrin-coated ves-
icles • transferrin receptor • recycling
 
Introduction
 
Receptor-mediated endocytosis (RME)
 
1
 
 is driven by the
clathrin-coated vesicle (CCV) cycle (Schmid, 1997). This
cycle begins with the assembly of the coat proteins, AP2,
and clathrin into coated pits. AP2 complexes concentrate
receptors and also mediate clathrin assembly at the plasma
membrane (PM) (Kirchhausen, 1999). Clathrin assembles
into a lattice-like structure and induces inward curvature
of the pit as it grows with the successive addition of coat
proteins. The coated pit invaginates and eventually de-
taches from the PM, forming a coated vesicle (Kirch-
hausen, 2000). The CCV cycle is completed when the coat
components are released and recycled.
One factor implicated in releasing coat proteins from
CCVs is hsc70. This chaperone was purified as a factor
that released clathrin from isolated coated vesicles in an
ATP-dependent manner (Schlossman et al., 1984). More
recently, hsc70 was also identified as a requirement for
AP2 release from isolated CCVs (Hannan et al., 1998).
Hsc70 is a constitutive member of the heat shock protein
family and is thought to function in multiple cellular pro-
cesses, including the folding of nascent chain polypeptides,
the translocation of proteins across membranes, and the
prevention of protein aggregation under stress conditions
(Mayer and Bukau, 1998). These diverse hsc70 activities
are, in part, facilitated through interactions with a series of
DnaJ-like proteins (Kelley, 1999). The supporting role
played by DnaJ-like proteins is demonstrated by auxilin,
which mediates the CCV uncoating reaction (Ungewickell
et al., 1995). Auxilin serves to recruit hsc70 to CCVs and
concomitantly stimulates hsc70 ATPase activity (Holstein
et al., 1996; Barouch et al., 1997). In its ADP-bound state,
hsc70 exhibits high affinity for protein substrates, includ-
ing clathrin (Prasad et al., 1994).
 
Hsc70 has been implicated in many cellular processes,
but it has been difficult to establish these activities in vivo.
To this end, an anti-hsc70 mAb was used in microinjection
studies to characterize the involvement of hsc70 in the
 
clathrin uncoating reaction in vivo
 
 
 
(Honing et al., 1994).
Microinjection of anti-hsc70 caused a prolonged colocal-
ization between internalized ligand and clathrin and an ac-
 
J
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cumulation of coated pits at the cell surface. These in vivo
studies supported a role for hsc70 in CCV disassembly and
suggested that it might have additional functions within the
CCV cycle. However, due to the single cell nature of this
assay, neither the accumulating coated structures nor the
nature of the endocytic block could be further analyzed.
An alternate approach was used to probe the cellular
functions of the hsc70-related protein BIP. Overexpres-
sion of dominant interfering mutants of BIP was used to
reveal its involvement in the maintenance of ER morphol-
ogy in mammalian cells (Hendershot et al., 1995). To ini-
tially determine whether this approach could be used to
explore hsc70 function in vivo, we generated and charac-
terized several hsc70 ATPase domain mutants defective in
CCV uncoating and found that they inhibited the wild-
type hsc70–mediated release of clathrin from isolated
CCVs. We next examined the effect of overexpression of
the dominant-interfering hsc70 mutants on the CCV cycle
using assays that allow dissection of discrete events in en-
docytosis.
 
 
 
Our findings support a role for hsc70 in the
clathrin uncoating reaction in vivo but, more strikingly,
suggest novel roles for hsc70 in chaperoning cytosolic
clathrin and in endosomal trafficking.
 
Materials and Methods
 
Reagents
 
The following mAbs were gifts from the indicated individuals: anti–
 
a
 
adaptin AP.6 and anticlathrin TD1 from F.M. Brodsky (University of Cal-
ifornia at San Francisco, San Francisco, CA), anti–transferrin receptor
(TfnR) D65 from I. Trowbridge (Salk Institute, La Jolla, CA), anti–300-
kD mannose-6 phosphate receptor (MPR) from S. Pfeffer (Stanford Uni-
versity, Stanford, CA), anti-
 
b
 
1/
 
b
 
2 adaptin 100/1 from E. Ungewickell
(Hanover Medical School, Hanover, NH), anti-hsc70/hsp70 3C5 from
B.M. Jockusch (University of Cologne, Cologne, Germany), and anti-
hemagglutinin (HA) 12CA5 from I. Wilson (The Scripps Research Insti-
tute, La Jolla, CA). Polyclonal antibodies were kindly provided as follows:
anticlathrin light chain from F. M. Brodsky, anti-MPR from S. Pfeffer, and
anti–
 
d
 
 adaptin from M.S. Robinson (Cambridge University, Cambridge,
MA). Anti-DnaK SPA-880 and anti-hsp70 SPA-810 were obtained from
StressGen Biotechnologies. Additional chemicals were of reagent grade.
Biotinylated transferrin (BXX-Tfn) was generated as described previ-
ously (Smythe et al., 1992).
 
Preparation of cDNA Constructs
 
Constructs BovHsc70.pRSET.wt, encoding full-length hsc70
 
WT
 
, and
BovHsc70.pT7-7.D199S and BovHsc70.pT7-7.K71M, encoding 60-kD NH
 
2
 
-
terminal hsc70 mutant fragments, were generously supplied by D.B. Mc-
Kay (Stanford University, Stanford, CA). For protein expression, pT7-
7.Hsc70WT was generated using NdeI/HindIII sites to exchange the
sequence encoding the full-length wild-type protein from pRSET.wt into the
pT7-7 vector. DNA encoding the COOH-terminal domains of hsc70 was re-
stored to the above truncated mutant constructs using NdeI/BlpI restriction
sites. Full-length pT7-7.Hsc70.T204V was generated using QuikChange
Mutagenesis kit (Stratagene) (forward primer, GATTTAGGGGGT-
GGCGTTTTTGATGTG; reverse primer, CACATGAAAAACGCCAC-
CCCCTAAATC). An HA tag was introduced at the NH
 
2
 
 terminus of hsc70
by ligating a cassette of synthetic oligomers (forward primer,
 
 
 
CATGGA-
GTATGATGTTCCTGATTATGCTCA; reverse primer,
 
 
 
TATGAGC-
ATAATCAGGAACATCATACTCCA) within the NdeI site of pT7-
7.Hsc70WT.
For adenoviral expression, the XbaI-excised HA-hsc70–encoding frag-
ment of pT7-7.HA-Hsc70 was subcloned into pADtet7, which carries the
tetracycline-regulated promoter. Mutations were introduced into this con-
struct by swapping in the PstI-excised fragment from the corresponding
mutant pT7-7.Hsc70. The generated constructs were sequenced to verify
correct engineering by the The Scripps Research Institute Protein and Nu-
cleic Acids Core Facility.
 
Proteins
 
CCVs were purified from either fresh or frozen bovine brain (Hannan et
al., 1998). Protein concentration was determined by Coomassie Protein
Assay (Pierce Chemical Co.). All recombinant proteins were expressed in
BL21(DE3) and harvested by lysis in buffer A (20 mM Hepes, pH 7, 1
mM EDTA, 1 mM DTT, 0.5 mM PMSF) supplemented with 25 mM KCl.
Native hsc70 was purified from the first high speed supernatant obtained
from the bovine brain CCV preparation. Native and recombinant hsc70
proteins, including HA-hsc70, were purified by sequential chromatogra-
phy first on Q-Sepharose (2.5 
 
3 
 
16 cm; Amersham Pharmacia Biotech)
and then on ATP agarose (catalogue no. 2767; 1.5 
 
3
 
 15 cm; Sigma-
Aldrich) as described (Schlossman et al., 1984; Greene and Eisenberg,
1990). The resulting protein was precipitated with 75% (NH
 
4
 
)
 
2
 
SO
 
4
 
 in the
presence of 10 mM EDTA to promote the dissociation of ATP (Buxbaum
and Woodman, 1996). Recombinant hsc70 was further purified by size ex-
clusion chromatography on Superose S-300 (1.5 
 
3
 
 95 cm; Amersham
Pharmacia Biotech) in buffer A containing 100 mM KCl, followed by
chromatography on Q-Sepharose (1.5 
 
3
 
 10 cm). Hsc70 was eluted with a
25–250-mM KCl linear gradient in buffer A (200 ml, 1 ml/min). The latter
column completely removed contaminating DnaK as verified by Western
blotting. The molar extinction coefficient, 
 
e
 
1%
 
 5 
 
6.2, was used to quantify
native and recombinant hsc70.
 
Adenoviral Expression of Hsc70 WT and Mutant 
Proteins in tTA HeLa Cells
 
Adenoviruses carrying the hsc70 genes were prepared from the pADtet7
hsc70 constructs as described earlier (Hardy et al., 1997; Altschuler et al.,
1998). Within this expression system, the gene is introduced under the
control of a tetracycline-repressible promoter. For all of the assays de-
scribed below, subconfluent dishes of cells were infected for 2 h with the
respective viruses at 400 pfu/cell and were subsequently incubated in fresh
DME/10% FBS for 16 h.
 
Fractionation Procedures
 
Oligomerization of Endogenous Hsc70. 
 
For analysis of hsc70 oligomeriza-
tion, 2 
 
3
 
 10
 
6
 
 cells were infected on 10-cm dishes. After infection, the
cells were released with PBS plus 5 mM EDTA, washed once with ice-
cold KH250KCl buffer (100 mM KOAc, 20 mM Hepes, 250 mM KCl,
complete protease inhibitors [Roche], pH 7.4) containing either 1 mM
MgOAc or 1 mM NaN
 
3
 
, 5 mM EDTA and 2 mM deoxyglucose (ATP-
depleting), and finally resuspended in 100 
 
m
 
l of the respective buffer.
After incubating the cells at 4
 
8
 
C for 10 min, cytosol was prepared
through rapid freeze/thaw and centrifugation at 20,000 
 
g
 
 for 5 min. The
supernatant was fractionated on Superdex 200 HR 10/30 (Amersham
Pharmacia Biotech) at 0.25 ml/min run with 20 mM Hepes, 100 mM KCl,
2 mM MgCl
 
2
 
, pH 7. Samples prepared with KH250KCl and 1 mM
MgOAc were incubated with 1 mM Mg
 
2
 
1
 
ATP and a regenerating system
for 10 min at 37
 
8
 
C before fractionation. Fractions were analyzed by
SDS-PAGE and Western blotting.
 
Subcellular Fractionation of Adenovirally Infected Cells. 
 
Infected cells
were released from 15-cm dishes with PBS plus 5 mM EDTA. The cells
(10
 
7
 
) were washed with 100 mM Mes, pH 6.2, 1 mM EGTA, 0.5 mM
MgCl
 
2
 
, 250 mM KCl, 250 mM sucrose and complete protease inhibitors,
resuspended in 200 
 
m
 
l of the same buffer, and disrupted by freeze–thaw.
Rigorous mixing via a Vortex and drawing the suspension through a 22-
gauge needle released coated vesicles from larger membranes. Subse-
quent centrifugation at 14,000 
 
g
 
 pelleted the heavy membranes including
the PM, Golgi, and endosomal compartments. The low speed supernatant
was centrifuged at 100,000 
 
g
 
, generating a high speed pellet containing the
vesicular pool and a high speed supernatant corresponding to the cytosolic
pool. Alternatively, the low speed supernatant was loaded onto an S-1000
column (1.0 
 
3
 
 90 cm; Amersham Pharmacia Biotech) run at 0.07 ml/min
(Phan et al., 1994). 2-ml fractions were collected, TCA precipitated, and
analyzed by SDS-PAGE and Western blotting.
 
Biochemical Assays
 
Clathrin Release Assay. 
 
Hsc70-mediated clathrin release was performed
for 8 min at 25
 
°
 
C in 20 mM Hepes, pH 7.0, 25 mM KCl, 2 mM Mg
 
2
 
1
 
/ATP
as previously described (Hannan et al., 1998).
 
Single Round Endocytosis and Recycling from the Endosomal Compart-
ment. 
 
The internalization of prebound BXX-Tfn was performed as de-
scribed previously (Sever et al., 2000). 
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Determination of Surface-bound TfnR. 
 
The steady state distribution of
surface-bound TfnR was determined by monitoring the relative amounts
of BXX-Tfn that bound to virally infected cells in the absence and pres-
ence of saponin. After the infection of 10
 
5
 
 cells grown in 12-well plates,
the cells were washed twice with ice-cold PBS, 1 mM MgCl
 
2
 
, and 1 mM
CaCl
 
2
 
 (PBS
 
2
 
1
 
). For the subsequent 4
 
8
 
C washes that follow, the cells in half
the wells were permeabilized with PBS
 
4
 
1
 
/0.05% saponin, and the cells in
the remaining wells were left intact and washed with PBS
 
4
 
1
 
. The cells
were initially incubated with PBS
 
4
 
1
 
 
 
6 
 
saponin for 30 min and subse-
quently were incubated with 4 
 
m
 
g/ml BXX-Tfn in PBS
 
4
 
1
 
 
 
6 
 
saponin for
2 h. The cells were then washed four times with PBS
 
4
 
1
 
 
 
6 
 
saponin and
twice with PBS. To determine total cell-associated BXX-Tfn, the cells
were lysed in blocking buffer (10 mM Tris HCl, pH 7.6, 50 mM NaCl, 1
mM EDTA, 0.1% SDS, 1% Triton X-100, 0.2% BSA), and BXX-Tfn was
quantified by ELISA, as described previously (Damke et al., 1994).
 
Tfn Receptor Biosynthesis. 
 
Trafficking of a pulse of 
 
35
 
S-labeled TfnR
through the Golgi region was monitored by the acquired resistance to en-
doglycosidase H (Endo H) cleavage and by the addition of complex oli-
gosaccharides as described previously (Omary and Trowbridge, 1981;
Damke et al., 1994).
 
Fluid Phase Uptake. 
 
HRP was used as a bulk flow marker as described
earlier (Damke et al., 1994).
 
Internalization of Alexa
 
488
 
-Tfn. 
 
For immunofluorescence experiments,
cells were grown and infected on coverslips. To follow RME, a final con-
centration of 50 
 
m
 
g/ml Alexa
 
488
 
-Tfn (Molecular Probes) was incubated
with PBS-washed cells for 5 min at 37
 
8
 
C. The coverslips were rinsed with
PBS
 
2
 
1
 
 and incubated with 100 
 
m
 
g/ml unlabeled Tfn. At designated times,
the coverslips were placed at 4
 
8
 
C, and at the completion of the time course
the coverslips were washed with PBS
 
2
 
1
 
, subjected to a 2 min 37
 
8
 
C acidic
wash (Dautry-Varsat et al., 1983) that removed the majority of bound Tfn
as indicated by the respective 4
 
8
 
C control, and washed again with PBS
 
2
 
1
 
.
Cells labeled with Alexa
 
488
 
-Tfn, as well as unlabeled cells used for addi-
tional labeling studies, were fixed with 3% formaldehyde and solubilized
with PBS
 
2
 
1
 
/0.1% saponin/5% goat serum. Subsequent to fixation and per-
meabilization, cells were incubated with primary antibodies as indicated in
the figure legends and these were detected with the following secondary
antibodies: Texas red–labeled goat anti–rabbit and goat anti–mouse (Mo-
lecular Probes) and FITC-labeled goat anti–mouse (Sigma-Aldrich). A
Zeiss Axiovert 100TV and Spot 32 camera were used to collect digital epi-
fluorescent images. Additional immunofluorescence data were collected
with a confocal microscope (MRC 1024; Bio-Rad Laboratories).
 
Online Supplemental Material
 
Figure S1 shows EM images taken of thin sections prepared from epon-
embedded, adenovirally infected tTA HeLa cells. Similar cell morphology
is observed between hsc70
 
WT
 
- and hsc70
 
K71M
 
-expressing cells. The supple-
mental figure and legend are available at http://www.jcb.org/cgi/content/
full/152/3/607/DC1.
 
Results
 
Hsc70 ATPase Domain Mutants Are
Dominant-interfering In Vitro
 
To identify hsc70 ATPase-deficient mutants that could
dominantly interfere with hsc70 function in vivo, we as-
sayed three hsc70 mutants in the in vitro clathrin uncoat-
ing reaction. The mutated residues (K71, D199, and
T204) are all found within the nucleotide binding site
(Flaherty et al., 1991) and were originally introduced to
understand their contribution to hsc70 ATPase cycling.
Hsc70
 
T204V
 
 was formerly characterized within the full-
length protein and exhibited normal rates of ATP hydrol-
ysis but bound ATP 
 
z
 
100-fold more weakly than hsc70
 
WT
 
(O’Brien and McKay, 1993). Hsc70
 
D199S
 
 and hsc70
 
K71M
 
were previously characterized within the 44-kD ATPase
fragment and exhibited ATPase rates that were either 50-
fold reduced or undetectable compared with hsc70
 
WT
 
, re-
spectively (Wilbanks et al., 1994; O’Brien et al., 1996).
Analysis of a 60-kD fragment containing the ATPase and
 
substrate binding domain suggested that these latter two
mutants were also impaired in their ability to yield an
ATP-induced conformational change (Johnson and Mc-
Kay, 1999). The ATPase properties of these mutants in
the context of full-length hsc70 will be described in detail
elsewhere (Newmyer, S.L., and S.L. Schmid, manuscript
in preparation).
None of the hsc70 ATPase domain mutants could effi-
ciently release clathrin from CCVs, even when present at
fivefold higher concentrations compared with the recom-
binant wild-type protein (Fig. 1 A). Thus, as has been ob-
served in vitro with hsp70 ATPase domain mutants (Raja-
pandi et al., 1998), proper ATPase cycling was required
for hsc70-mediated CCV uncoating activity. To learn
whether the hsc70 mutants could be used in vivo to dis-
rupt hsc70 function, the mutant proteins were titrated into
the CCV uncoating reaction mediated by native hsc70, pu-
rified from brain cytosol. All three of the mutants inter-
fered with the ability of hsc70
 
Native
 
 to mediate clathrin re-
lease (Fig. 1 B). Inhibition of the uncoating reaction
occurred in a saturable manner with half maximal inhibi-
tion occurring at approximately fourfold excess of either
hsc70
 
K71M
 
 or hsc70
 
T204V
 
 to hsc70
 
Native
 
. Hsc70
 
D199S
 
 also in-
Figure 1. Hsc70 ATPase domain mutants inhibit hsc70-mediated
clathrin uncoating. CCVs were incubated in the presence of wild-
type and mutant hsc70 proteins. (A) Shown is a Coomassie blue–
stained gel of clathrin released into the 100,000-g supernatant.
The final mM concentration of recombinant protein used is indi-
cated in parenthesis. (B) The uncoating reaction mediated by
hsc70Native (0.4 mM) was assayed in the presence of increasing
hsc70 mutant concentration. The error bars reflect the SD from
three independent experiments. WT, wild type. 
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hibited hsc70
 
Native
 
-mediated clathrin release, though at
higher concentrations. Thus, these mutants have domi-
nant-interfering effects and can be used to probe hsc70
function in the cell.
 
Overexpression of Hsc70 ATPase Mutants in 
Adenovirally Infected tTA HeLa Cells
 
Hsc70 is abundant, constituting 
 
z
 
1–2% of total cellular
protein, and can be detected by Coomassie blue staining of
cell lysates (Fig. 2 A, the identity of each species was con-
firmed by Western blotting). To generate robust hsc70
ATPase mutant expression, we used a tetracycline-regu-
lated adenoviral expression system. The cDNA encoding
the wild-type and mutant hsc70 proteins included a se-
quence encoding an NH
 
2
 
-terminal HA tag in order to dis-
tinguish the overexpressed protein from the endogenous
protein. Control experiments established that the HA tag
did not significantly affect the properties of recombinantly
generated hsc70 (data not shown). Reasonable overex-
pression (approximately threefold) of the mutant protein
relative to endogenous hsc70 was attained at high viral lev-
els, 400 pfu/cell (Fig. 2 A). Interestingly, some induction of
 
hsp70, the inducible form of hsc70, was seen in cells ex-
pressing hsc70
 
K71M
 
 and hsc70
 
T204V
 
. Within these cells, the
level of hsp70 equaled that of endogenous hsc70, suggest-
ing that overexpression of inhibitory hsc70 mutants might
stress the cell. Under these conditions, however, infected
cells exhibited normal morphology as observed by light
microscopy and EM analysis (online supplemental Figure
S1, available at http://www.jcb.org/cgi/content/full/152/3/
607/DC1). If higher viral concentrations were used with
expression of the mutant proteins, cells would round up
and detach. Potential aberrant effects arising from the use
of high virus levels were controlled by assaying a sample
infected with hsc70
 
K71M
 
 virus in the presence of tetracy-
cline to repress expression of the adenovirally introduced
gene (Fig. 2 A).
 
Hsc70 ATPase Domain Mutants Dominantly Interfere 
with Tfn Endocytosis and Recycling
 
Based on in vitro findings, we predicted that the hsc70
mutant–expressing cells would exhibit a CCV uncoating
defect provided that hsc70 indeed functions in clathrin
uncoating in vivo and that our expression system sup-
Figure 2. Overexpression of
hsc70 mutants dominantly in-
terferes with TfnR endocyto-
sis and recycling. (A) Ade-
novirally infected tTA HeLa
cells overexpressing hsc70
wild-type and mutant pro-
teins were harvested 18 h af-
ter infection and analyzed by
SDS-PAGE and Coomassie
blue staining. The 70-kD hsc/
hsp70 bands are shown.
Western blotting with anti-
bodies 3C5, SPA-810, and
12CA5 identified the hsc/
hsp70 species as indicated.
(B) Adenovirally infected
tTA HeLa cells expressing
wild type (d), D199S (r),
K71M (m), and T204V (j)
hsc70 were assayed for a sin-
gle round of BXX-Tfn up-
take and recycling. Control
cells (n) were infected with
hsc70K71M-encoding adenovi-
ruses but were cultured in
the presence of tetracycline
to suppress expression. The
inset expands the data col-
lected within the initial 5
min.  The error bars reflect the
SD from three independent
experiments. WT, wild type. 
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plied enough mutant protein. An uncoating defect would
limit the cellular sorting of Tfn and prevent its recycling.
Accordingly, we assayed a single round of trafficking of
surface-bound BXX-Tfn in the virally infected cells. In
both control and hsc70
 
WT
 
-expressing cells, Tfn was en-
docytosed rapidly, within 5 min, and the internalized
ligand was efficiently recycled (
 
t
 
1/2 
 
<
 
15 min) out to the
cell surface (Fig. 2 B, 
 
n 
 
and 
 
d
 
). The mutant-expressing
cells demonstrated dramatically different Tfn trafficking
 
kinetics. Consistent with in vitro studies, and supporting
a role for hsc70 in CCV uncoating, these cells exhibited
significant recycling defects, whereby Tfn remained in
the hsc70 mutant expressing cells 
 
.
 
60 min after internal-
ization. The recycling defect was most striking with over-
expression of hsc70
 
T204V
 
 (
 
j
 
) and hsc70
 
K71M
 
 (
 
m
 
) with es-
sentially all of the internalized Tfn remaining within the
cell. Interestingly, the mutant-expressing cells also dem-
onstrated endocytosis defects, which in strength were
Figure 3. The trafficking of
newly synthesized TfnR is
slightly inhibited by domi-
nant-interfering hsc70 mu-
tants. Autoradiogram (A)
and corresponding quantita-
tion (B and C) of immuno-
precipitated TfnR from a
representative experiment.
(B) Trafficking of TfnR from
the ER (eHs) to the cis-Golgi
region (eHr) was monitored
through the resistance to
Endo H. (C) Trafficking to
the trans-Golgi region was
assayed through the shift of
glycosylation from the imma-
ture (i) to mature (m) recep-
tor state. WT, wild type. 
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proportional to their corresponding recycling defects
(Fig. 2 B, inset). Expression of hsc70
 
D199S
 
, hsc70T204V, and
hsc70K71M decreased the initial rate of Tfn uptake 1.4-,
2.7- and 10-fold, respectively, relative to control and wild
type–expressing conditions.
The data described above were generated by quenching
external BXX-Tfn with avidin, a relatively large probe
that masks the biotin molecule at early stages of endocyto-
sis but cannot access BXX-Tfn when it becomes seques-
tered into constricted coated pits (Schmid, 1997). We also
monitored late stages of endocytosis with BSS-Tfn where
the disulfide linkage between the biotin and ligand can be
cleaved by smaller probes that reduce this bond. Com-
pared with BXX-Tfn uptake, similar results were obtained
when endocytosis was measured using BSS-Tfn as ligand,
and the uptake into sealed CCVs was assessed by resis-
tance to the small membrane impermeant reducing agent,
MesNa (data not shown). This suggested that endocytic
CCV formation was inhibited in the mutant-expressing
cells before the formation of constricted coated pits. Thus,
these dominant-interfering hsc70 mutants appeared to in-
hibit at least two stages of the CCV cycle, initial coated pit
formation and a postbudding step.
Specificity of Inhibitory Effects of Dominant-interfering 
Hsc70 Mutants
Given the many possible functions of hsc70 within the cell,
overexpression of dominant-interfering hsc70 mutants
might have a global effect on cell viability. Therefore, to
learn whether the inhibitory effects of hsc70 ATPase do-
main mutants on endocytosis and recycling were specific,
we determined the effects of overexpression of hsc70WT or
hsc70K71M, the most potent mutant, on vesicular trafficking
along the secretory pathway. Cells were pulse labeled with
[35S]methionine, and the delivery of newly synthesized
TfnR from the ER to cis- and trans-Golgi compartments
was monitored by acquisition of Endo H resistance and
the addition of complex oligosaccharides, respectively.
Quantitation of the results shown in Fig. 3 A reveal that
Endo H–resistant (Fig. 3 B) and mature (Fig. 3 C) forms of
TfnR appeared at similar rates in control and hsc70WT-
expressing cells. The corresponding rates observed in
hsc70K71M-expressing cells were slightly inhibited (approx-
imately twofold). The rates of biosynthesis and transloca-
tion of TfnR into the ER, as assessed by radiolabel in-
corporation and addition of core oligosaccharides, were
also not significantly inhibited with overexpression of
hsc70K71M (data not shown). Thus, TfnR biosynthesis was
only slightly inhibited by the most potent inhibitor of
BXX-Tfn uptake and recycling.
To further gauge the specificity of inhibition of RME
and recycling by hsc70 mutants, we measured the internal-
ization kinetics of the fluid phase marker, HRP. Normaliz-
ing to the control condition, cells expressing hsc70WT,
hsc70D199S, hsc70T204V, and hsc70K71M exhibited the follow-
ing rates of fluid phase uptake: 0.91 6 0.14, 1.01 6 0.18,
0.72 6 0.09, and 0.70 6 0.20 arbitrary peroxidase U/mg cel-
lular protein/min. A slight inhibitory trend was observed
with expression of the two most potent mutants, hsc70T204V
Figure 4. Overexpression of
hsc70K71M causes endoge-
nous hsc70 to migrate as a
complex. Size exclusion chro-
matography was employed to
monitor the potential oligo-
merization of endogenous
hsc70. The independent mi-
gration of alcohol dehydroge-
nase (150 kD) and BSA (66
kD) are shown as markers.
Western blotting with 3C5 re-
vealed the migration of en-
dogenous hsc70, hsp70, and
the HA-tagged adenovirally
expressed mutant and wild-
type hsc70 and was quantified
through densitometric scan-
ning. WT, wild type.Newmyer and Schmid Hsc70 Mutants Disrupt the CCV Cycle In Vivo 613
and hsc70K71M. Bulk fluid uptake and trafficking through
the Golgi compartments, thus, were both slightly affected
in the mutant-expressing cells, suggesting that hsc70 might
play a limited role in these processes or that cell viability is
slightly compromised by the hsc70 mutants. In contrast to
these small effects, overexpression of all hsc70 ATPase
mutants significantly inhibited endocytosis and recycling
(Fig. 2 B). In the most potent case, endocytosis was inhib-
ited 10-fold, and recycling was no longer detected. Thus, in
comparison with other trafficking events, the potent effects
of the dominant-interfering hsc70 ATPase mutants appear
to be specific for TfnR endocytosis and recycling.
Ultrastructural analysis of adenovirally infected cells
overexpressing hsc70wt and hsc70K71M (online supplemen-
tal Figure S1, available at http://www.jcb.org/cgi/content/
full/152/3/607/DC1) also did not reveal differences in the
ER, mitochondria, Golgi regions, or PM when compared
with uninfected cells, providing further evidence against a
general effect on cell viability.
Overexpression of Mutant Hsc70s Sequesters 
Endogenous Hsc70 in a Complex
Given that the hsc70 mutants specifically disrupt Tfn up-
take and recycling, we were interested in exploring the
mechanism by which the endogenous protein was inhib-
ited. We hypothesized that these mutants could inhibit
through (a) sequestration of clathrin, (b) sequestration of
auxilin, the DnaJ protein that is thought to target hsc70 to
clathrin, and/or (c) sequestration of endogenous hsc70. In
vitro, hsc70 forms a stable complex with clathrin and auxi-
lin (Schmid and Rothman, 1985; Holstein et al., 1996);
however, we were unable to detect similar complexes
with the hsc70 mutants (Newmyer, S.L., and S.L. Schmid,
manuscript in preparation), suggesting that inhibition is
not due to sequestration of either clathrin or auxilin. In
contrast, the mutant hsc70s could form dimers and
higher  order oligomers with hsc70WT as detected through
crosslinking (data not shown). Hsc70 oligomerization is
promoted in the presence of ADP, and it has been sug-
gested that oligomerization inhibits hsc70 activity (Ben-
aroudj et al., 1996; Gao et al., 1996). Given that our mu-
tants have aberrant ATPase cycles, we looked for their
ability to oligomerize with endogenous hsc70 by using size
exclusion chromatography to monitor the presence of such
complexes in the hsc70 expressing cells (Fig. 4). In the
hsc70WT-expressing cells (solid line), the endogenous and
HA-tagged proteins coeluted just before the BSA stan-
dard. Incubation of the lysate with ATP did not alter this
elution profile (data not shown), suggesting that under
Figure 5. Subcellular frac-
tionation of hsc70WT- and
hsc70K71M-expressing and
control cells. (A) Western
blot analysis of the crude
subcellular distribution of
coat proteins and receptors
includes the total cellular
(T), the 14,000-g pelleted
heavy membrane (P1), the
100,000-g pelleted vesicular
membrane (P2), and the cy-
tosolic (S) pools. (B) West-
ern blot analysis of fractions
17–31 collected from an
S-1000 column show the mi-
gration of vesicular and cyto-
solic proteins within the low
speed supernatant. The mi-
gration of purified CCVs and
clathrin is indicated. Anti-
clathrin TD1, anti-b1/b2
adaptin 100/1, anti–d adaptin,
and anti–TfnR D65 were
used for immunoblotting.
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these conditions hsc70 existed as a monomer (Angelidis et
al., 1999). Strikingly, in cells overexpressing the K71M mu-
tant, endogenous hsc70 coeluted with hsc70K71M as a
higher molecular weight species (dashed line), suggesting
that these proteins exist in a complex. We could not deter-
mine whether other cytosolic proteins were also present in
this complex. As with hsc70WT cells, the elution profiles
observed were unaffected by incubation under ATP-
depleting and -supplementing conditions, indicating that
the faster migrating hsc70 species is stable to the addition
of ATP (data not shown). These results suggested that the
overexpression of hsc70 ATPase–deficient mutants cre-
ated a new equilibrium between active monomeric and po-
tentially inactive oligomeric hsc70 species and that by
overexpressing these mutants we have, in effect, seques-
tered the endogenous protein.
The Unassembled Cytosolic Pool of Clathrin Is 
Depleted in Cells Overexpressing Dominant-interfering 
Hsc70 Mutants
We next tested whether CCVs indeed accumulate in hsc70
mutant expressing cells as suggested by our observed recy-
cling defect. To examine this, we performed subcellular
fractionation of control and hsc70-expressing cells. Lysed
cells were fractionated by low and high speed centrifuga-
tion to obtain pellets containing heavy membrane (P1)–
and vesicular membrane (P2)–associated proteins, respec-
tively, and the remaining supernatant was used to identify
cytosolic protein (S). In control and hsc70WT-expressing
cells, clathrin was distributed evenly between the heavy
membrane and cytosolic pools (Fig. 5 A). Strikingly, in
hsc70K71M-expressing cells, the majority of the cytosolic
Figure 6. Internalized Tfn
exhibits prolonged traffick-
ing through punctate struc-
tures in hsc70D199S- and
hsc70T204V-expressing cells as
visualized by epifluorescent
microscopy. A 5-min pulse of
Alexa488-Tfn (0 min) was
chased with unlabeled Tfn
and followed for 5, 10, 20,
and 30 min. Cells were
fixed  and processed for fluo-
rescence microscopy as de-
scribed in Materials and
Methods. All images were
collected with 2-s exposures.
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pool of coat proteins was lost, and the vesicular pool corre-
spondingly increased. Similar results were observed in
hsc70D199S- and hsc70T204V-expressing cells, with the degree
of accumulation of clathrin in the P2 pool being propor-
tional to the relative inhibitory strengths of the mutants
(i.e., K71M . T204V . D199S; data not shown). To fur-
ther characterize the vesicular versus cytosolic pools, the
low speed supernatant was fractionated by size exclusion
chromatography to resolve triskelions from assembled
clathrin cages. The majority of clathrin migrated as triskel-
ions in control and hsc70WT-expressing cells but, consistent
with our subcellular fractionation findings, migrated like
assembled clathrin in the hsc70K71M-expressing cells (Fig. 5
B). A strong uncoating defect would predict such an in-
creased CCV phenotype. Moreover, AP1 and AP2 cofrac-
tionated with clathrin in the hsc70K71M-expressing cells as
would be expected if uncoating were inhibited. Recall that
hsc70 is required for adaptor protein (AP) release from
purified CCVs (Hannan et al., 1998). We also looked at
AP3, which has been implicated in clathrin-dependent and
-independent sorting at the TGN and endosomes (Simp-
son et al., 1996; Dell’Angelica et al., 1998). In contrast to
AP1 and AP2, we find that AP3 fractionated indepen-
dently of the assembled pool of clathrin in hsc70K71M-
Figure 7. Internalized Tfn is largely associated with punctate AP2-free structures in mutant hsc70–expressing cells. Confocal micros-
copy was employed to monitor the colocalization of AP2 (red) with Alexa488-Tfn (green). Hsc70 mutant–expressing cells internalized
Alexa488-Tfn for 5 min and then were chased for 5 and 20 min. The cells were subsequently fixed and processed. The mAb AP.6 immu-
nolabeled a-adaptin. Arrows mark punctate colabeled structures. WT, wild type.The Journal of Cell Biology, Volume 152, 2001 616
expressing cells (Fig. 5, A and B). Relative to control and
hsc70WT-expressing cells, AP3 was not increased in the
high speed pellet, and its migration on the S-1000 column
was not altered, consistent with reports that AP3 can func-
tion independently of clathrin (Faundez and Kelly, 2000).
Disruption of hsc70 activity, therefore, causes a striking
redistribution of clathrin, AP1, and AP2 to an assembled
pool that is consistent with there being a block in un-
coating of the corresponding TGN-, endosome-, and PM-
derived CCVs.
Hsc70 Mutants Inhibit the Transit of TfnR through the 
Endosomal Compartment
Given that the hsc70 ATPase-deficient mutants inhibited
CCV uncoating mediated by the wild-type protein in vitro,
we expected that overexpression of these mutants might
also disrupt CCV disassembly in vivo. We have thus far
provided strong evidence that disruption of hsc70 function
in vivo alters the steady state distribution of clathrin from
the disassembled to assembled states. The potent inhibi-
tion of BXX-Tfn recycling would suggest that internalized
TfnR might accumulate in newly formed endocytic CCVs.
However, when we examined the distribution of TfnR us-
ing subcellular fractionation, we were unable to detect an
accumulation in the vesicular pool as determined either by
differential centrifugation (Fig. 5 A) or by chromatogra-
phy on S1000 (data not shown). Nor could we detect a
TGN-derived cargo molecule, the MPR (data not shown).
Therefore, to further elucidate the nature of the recycling
defect, we followed the trafficking of a 5-min pulse of
Alexa488-Tfn. For these experiments, we studied cells ex-
pressing the weaker D199S and T204V hsc70 mutants be-
cause they incorporated a significant amount of labeled
Tfn within the 5-min pulse time. In control (data not
shown) and hsc70WT-expressing cells, internalized Tfn was
initially found in punctate structures resembling vesicles
but rapidly trafficked to the perinuclear recycling endo-
some and back out of the cell (Fig. 6). In contrast, the mu-
tant cells exhibited prolonged punctate staining that was
still detectable 30 min after internalization. To determine
whether these punctate structures were endocytic CCVs,
the Alexa488-Tfn–internalized cells were immunolabeled
with anti-AP2. Normally, the release of coat proteins from
CCVs occurs within 1 min of budding, and punctate struc-
tures labeling for both coat protein and internalized Tfn
are rare. Accordingly, in control (data not shown) and
Figure 8. Steady state distri-
bution of TfnR and MPR in
wild-type and mutant hsc70–
expressing cells. The cellular
localization of PM- and TGN-
cycled receptors were visual-
ized by epifluorescent micros-
copy. Anti–TfnR D65 and
anti-MPR antibodies were
used to label adenovirally in-
fected cells after their fixa-
tion. Arrows indicate the tu-
bular TfnR-labeled structures
observed in hsc70K71M-express-
ing cells. WT, wild type.Newmyer and Schmid Hsc70 Mutants Disrupt the CCV Cycle In Vivo 617
hsc70WT-expressing cells, AP2 and Alexa488-Tfn colocalize
in only a few punctate structures at 5 min after internaliza-
tion and are completely separated after 20 min (Fig. 7). In
contrast, AP2 and Tfn colocalization within punctate
structures could be detected even 20 min after internaliza-
tion in the D199S- and T204V hsc70–expressing cells, sug-
gesting that the uncoating reaction was significantly inhib-
ited (Fig. 7). Similar results were obtained with clathrin
labeling and after necessarily longer times of Alexa488-Tfn
uptake (30 min) into cells expressing hsc70K71M (data not
shown). Surprisingly, in the mutant-expressing cells, only a
few costained punctate structures were found even at 5
min after internalization, demonstrating that CCV uncoat-
ing is not potently inhibited in these cells. Nonetheless,
finding that the majority of Alexa488-Tfn–labeled struc-
tures did not costain for AP2 was consistent with the frac-
tionation experiment, demonstrating that assembled AP2–
clathrin structures accumulated independently of TfnR.
Together these data suggest that the accumulating coated
structures might represent empty cages.
In hsc70 mutant–expressing cells, recycling of internal-
ized BXX-Tfn was blocked (Fig. 2 B); yet, immunolabel-
ing studies demonstrated that CCV uncoating was only
partially inhibited. These data suggest that other postun-
coating trafficking events were also inhibited by the hsc70
mutants. Analysis of trafficking of Alexa488-Tfn through
endosomal compartments confirmed this suggestion. In
control and hsc70WT-expressing cells, Tfn strongly labels
the perinuclear recycling endosome within the initial 5-min
uptake period (Fig. 6, 0 chase). In contrast, there was
considerably less accumulation of Alexa488-Tfn in the recy-
cling endosome in mutant hsc70 cells, and accumulation
appeared to be delayed 5–10 min relative to hsc70wt cells
(Fig. 6). The fluorescence data also demonstrated that
punctate staining was substantially lost after 20 min of
chase; yet, hsc70 mutant–expressing cells accumulate
BXX-Tfn so that, after 60 min of incubation, the majority
of internalized molecules remain in the cell (Fig. 2 B). Col-
lectively, our findings indicate that, 20 min after internal-
ization, Tfn is localized diffusely throughout the cell and
suggest that vesicular trafficking to the cell surface is also
inhibited. Thus, the recycling defect found in hsc70 mu-
tant–expressing cells is apparently due to inhibition of
multiple vesicular trafficking or sorting steps within the
endosomal compartment.
Hsc70 ATPase Mutants Cause a Redistribution of TfnR 
within the Cell
The overexpression of hsc70 ATPase mutants significantly
inhibited the trafficking of Tfn, suggesting that the traf-
ficking of the receptor was also inhibited. Therefore, we
monitored the steady state distribution of TfnR by immu-
nofluorescence to learn how its trafficking was affected by
the altered endocytic and recycling kinetics observed for
the hsc70 mutant–expressing cells. Accumulation of TfnR
within the recycling compartment was decreased, corre-
sponding to the increased inhibitory potency of the hsc70
mutant (Fig. 8). This was especially evident in cells ex-
pressing hsc70K71M where TfnR appeared to accumulate in
vesicular and tubular structures (arrows).
We also characterized the localization of MPR, which is
transported by CCVs between the TGN and late endo-
some, and found that this receptor was also more diffusely
localized in punctate structures in hsc70 mutant–express-
ing cells (Fig. 8). Consistent with results presented above,
neither TfnR nor MPR showed significant colocalization
with clathrin in the hsc70 mutant cells (data not shown).
The finding that multiple receptors were mislocalized in
hsc70 mutant–expressing cells further supports our hy-
pothesis that these hsc70 inhibitory mutants interfere with
sorting and trafficking within the endosomal compart-
ment.
Given that TfnR trafficking was decreased with overex-
pression of hsc70 mutants, we asked whether the endocy-
tosis defect (Fig. 2 B) was indirectly due to a decreased
number of receptors at the cell surface. To determine the
steady state extracellular distribution of TfnR, we mea-
sured and compared the binding of BXX-Tfn to virally in-
fected cells in the presence and absence of saponin. The
percentage of extracellular TfnR was found to be as fol-
lows: 16.6 6 7.8 for control, 18.1 6 6.5 for hsc70WT, 17.0 6
7.5 for hsc70D199S, 18.8 6 5.9 for hsc70T204V, and 37.6 6 15.3
for hsc70K71M cells (n 5 3 or 4), indicating that TfnR was
actually increased at the cell surface of hsc70K71M-express-
ing cells. A similar doubling of receptors at the cell surface
is observed when RME is inhibited by dynamin mutants
(Damke et al., 1994). The dramatic changes in the steady
state distribution of PM and TGN receptors observed in
hsc70K71M-expressing cells suggests that hsc70 plays multi-
ple roles in vesicle trafficking and RME.
Discussion
Hsc70 and the CCV Cycle
We have characterized several hsc70 ATPase–deficient
mutants and found them to dominantly interfere with the
CCV cycle in vivo. Within HeLa cells, clathrin is equally
distributed between assembled and unassembled pools.
Overexpresssion of hsc70 mutants dramatically shifts this
equilibrium towards the assembled state, demonstrating
that hsc70 plays a role in clathrin dynamics. We observed a
significant shift of clathrin and AP1–AP2 complexes into
fractions coeluting by size exclusion chromatography with
CCVs. We also found prolonged colocalization of AP2
and internalized Tfn in punctate structures, suggesting that
the increased assembled pool of clathrin and APs is in part
due to a CCV uncoating defect. Hsc70 was previously im-
plicated in releasing clathrin from CCVs based on in vitro
studies (Rothman and Schmid, 1986). The physiological
significance of hsc70-mediated uncoating was supported
by microinjection studies (Honing et al., 1994) and by the
discovery of a requirement for auxilin, a DnaJ-like protein
associated with neuronal CCVs in recruiting hsc70 to as-
sembled clathrin for uncoating (Ungewickell et al., 1995).
Recently, nonneuronal (GAK) and yeast (swa2p/aux1p)
homologues of auxilin have been identified (Gall et al.,
2000; Greener et al., 2000; Pishvaee et al., 2000; Umeda et
al., 2000). Deletion of swa2p/aux1p in yeast results in traf-
ficking phenotypes similar to that observed in clathrin-
deleted strains, as well as accumulation of coated vesicles
(Gall et al., 2000; Pishvaee et al., 2000). The in vivo effects
of interference with hsc70 function reported here are com-
plementary to results from yeast and, together, they estab-
lish that CCV uncoating is a general cellular function of
hsc70 (Fig. 9, step 1).The Journal of Cell Biology, Volume 152, 2001 618
Under normal conditions, endocytic CCVs are rapidly
uncoated (t1/2 < 1–2 min) and their contents are delivered,
through fusion, to early endosomes (t1/2 < 3 min) (Mukher-
jee et al., 1997). Overexpression of hsc70 mutants ap-
peared to delay the uncoating reaction and prolong the
life-time of endocytic coated vesicles; however, even at
early time points, only a relatively small population of in-
ternalized Tfn colocalized with AP2- or clathrin-labeled
structures. We were also unable to detect cargo molecules
in the AP2–AP1–clathrin-containing small vesicular frac-
tion. These results suggest that the uncoating reaction was
only partially inhibited, a result not unexpected given that
the overexpression levels achieved in vivo (threefold over
endogenous) were considerably less than those needed to
potently inhibit hsc70-mediated uncoating in vitro (.10-
fold over wild type). Nonetheless, even at these levels of
overexpression, we observed a quantitative redistribution
of cellular clathrin from the cytosolic pool to the high
speed pelleted fraction. One intriguing possibility that
could explain this discrepancy is that the assembled coated
structures that accumulate in the mutant cells and are pel-
letable at high speed are empty coats or misassembled lat-
tices (Fig. 9, step 2). This scenario would suggest a role for
hsc70 in maintaining clathrin (and perhaps APs) in an un-
assembled state and/or in regulating clathrin–AP assembly.
Clathrin and APs are known to spontaneously assemble
in vitro under physiological salt conditions, but how as-
sembly is regulated in the cell remains obscure. In vitro
studies demonstrate that hsc70 forms a stable complex
with clathrin during the uncoating reaction, which deters
hsc70 from performing additional rounds of uncoating
(Jiang et al., 2000). Hsc70 is known to stabilize many disas-
sembled or unfolded proteins, including steroid hormone
receptors and protein kinases (Morishima et al., 2000), and
has been implicated in chaperoning newly synthesized
clathrin during axonal transport (Black et al., 1991). Our
studies suggest that hsc70 may also chaperone cytosolic
clathrin within the CCV cycle, preventing assembly that is
not directed towards the PM or TGN. The hsc70 ATPase
mutants cannot bind clathrin stably in vitro and therefore
could probably not serve such a chaperone function in
vivo. This potential chaperone function would explain how
empty cages could accumulate in hsc70 mutant–expressing
cells disproportionately to CCVs labeled with Tfn.
Inhibition of functional clathrin assembly in hsc70 mu-
tant–expressing cells is also indicated by the observed
RME defect. We find that early rather than late stages of
RME are inhibited by overexpression of hsc70 mutants,
implicating a role for the endogenous protein in modulat-
ing coated pit growth (Fig. 9, step 3). It is likely that the
rate of coated pit assembly is decreased in mutant-express-
ing cells due to the partial depletion of cytosolic clathrin.
Additionally, inhibition of RME may reflect a more direct
role for hsc70 in chaperoning clathrin for functional as-
sembly at the coated pit. Further work is necessary to es-
tablish a direct role for hsc70 in coated vesicle formation.
Hsc70 and Endosomal Trafficking
Characterization of our hsc70 ATPase domain mutants
also reveals a role for this chaperone in TfnR recycling
(Fig. 9, step 4). Surprisingly, the recycling defect in hsc70
mutant–expressing cells could not be ascribed to a potent
block in CCV uncoating alone. Indeed, even the weakest
hsc70 mutant, D199S, was potently inhibitory, suggesting
that hsc70 is critically involved in other stages of TfnR
trafficking through the endocytic pathway. In the most po-
tently inhibited hsc70K71M-expressing cells, the internal-
ized BXX-Tfn does not appear to accumulate in the recy-
cling endosome, and, at steady state, both MPR and TfnR
become more diffusely distributed. Collectively, these
data suggest that multiple endosomal trafficking events
(early endosome®recycling endosome®PM and early en-
dosome®late endosome®TGN) are inhibited when hsc70
function is disrupted in vivo. Clathrin coats are well-char-
acterized in mediating vesicle formation at the PM and
TGN but have also been implicated in modulating endoso-
mal trafficking (Stoorvogel et al., 1996). APs have also
been associated with endosomally derived CCV formation
and may mediate specific endosomal sorting events (Fut-
ter et al., 1998; Sorkina et al., 1999; Meyer et al., 2000).
Hsc70 is likely to function in the uncoating and/or forma-
tion of all CCVs regardless of their origin. Consequently,
the potent recycling defect observed in hsc70 mutant–
Figure 9. Hsc70 is involved
in multiple steps in CCV cy-
cling and receptor recycling.
Hsc70 releases clathrin from
newly budded CCVs (1). Our
studies suggest that hsc70
may then be required to
chaperone cytosolic clathrin
triskelions (2) to allow their
functional recruitment to
coated pits (3). Within the
endosomal compartment,
hsc70 also promotes receptor
recycling (dashed line, 4).Newmyer and Schmid Hsc70 Mutants Disrupt the CCV Cycle In Vivo 619
expressing cells may, in part, reflect a cumulative CCV un-
coating/coated pit assembly defect expected for successive
vesicular trafficking events along the endocytic pathway.
Perturbation of endosomal trafficking may also arise, in
part, from inhibited vesicle motility. Multiple studies sug-
gest microtubule-based motility is required for endosomal
sorting. Recently, an in vitro assay reconstituting the sort-
ing of endosomal ligand from receptor was shown to
require microtubules and the motor protein kinesin (Ba-
nanis et al., 2000). A viable DnaJ-like motif was character-
ized within kinesin and was suggested to recruit hsc70 for
the dissociation of kinesin from vesicles (Tsai et al., 2000).
Perhaps the potent recycling defect observed in hsc70-
mutant cells is due to defective kinesin-dependent trans-
port of vesicles along microtubules. Our identification of
novel hsc70 roles will allow us to begin to elucidate the
mechanisms that regulate these events. In regards to the
CCV cycle, it will be especially interesting to learn how cy-
tosolic clathrin is maintained and what directs clathrin as-
sembly to the coated pit.
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